Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Total 13F shares
-
40,118,913
-
Share change
-
+4,460,347
-
Total reported value
-
$233,891,407
-
Price per share
-
$5.83
-
Number of holders
-
82
-
Value change
-
+$26,078,897
-
Number of buys
-
54
-
Number of sells
-
23
Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q1 2020
As of 31 Mar 2020,
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,118,913 shares.
The largest 10 holders included
NEA Management Company, LLC, Sarissa Capital Management LP, BlackRock Inc., VR Adviser, LLC, BVF INC/IL, Ghost Tree Capital, LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, Rock Springs Capital Management LP, and ACUTA CAPITAL PARTNERS, LLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.